top of page
knee wide4.jpg
Apex Clinical trials Logo.png

For patients diagnosed with Periprosthetic Joint Infection

Osteal Therapeutics has completed two prospective, randomized controlled trials comparing VT-X7 to standard of care, two-stage exchange arthroplasty.

For information on protocol design and participating sites for APEX, click here and for APEX-2 click here.

Osteal Therapeutics Announces Positive 12-Month Results from the APEX Clinical Trial Program at the 2024 American Association of 
 Hip and Knee Surgeons (AAHKS) Annual Meeting

For information on the expanded access program, click here.

For information on VT-X7, click here.
bottom of page